{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:00:59Z","timestamp":1792098059632,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ophtha.2012.02.018","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T17:25:40Z","timestamp":1335029140000},"page":"1575-1581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":200,"title":["Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients"],"prefix":"10.1016","volume":"119","author":[{"given":"Manuel","family":"D\u00edaz-Llopis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Salom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Garcia-de-Vicu\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Cordero-Coma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto","family":"Ortego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Suarez-de-Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Rio-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Fernandez-Cid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Fonollosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel M.","family":"Garcia-Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Benitez-del-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Olea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Fernando","family":"Arevalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2012.02.018_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00055735-199506000-00010","article-title":"Epidemiology of uveitis","volume":"6","author":"Smit","year":"1995","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.02.018_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1076\/ocii.10.4.263.15592","article-title":"Uveitis: a global perspective","volume":"10","author":"Chang","year":"2002","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2012.02.018_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","article-title":"Incidence and prevalence of uveitis in Northern California: the Northern California Epidemiology of Uveitis Study","volume":"111","author":"Gritz","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.02.018_bib4","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bjo.80.9.844","article-title":"The possible impact of uveitis in blindness: a literature survey","volume":"80","author":"Suttorp-Schulten","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.02.018_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/bjo.76.3.137","article-title":"Uveitis and systemic disease","volume":"76","author":"Rothova","year":"1992","journal-title":"Br J Ophthalmol"},{"issue":"Suppl","key":"10.1016\/j.ophtha.2012.02.018_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/02713689208999506","article-title":"Immunopathology and altered immunity in posterior uveitis in man: a review","volume":"11","author":"Lightman","year":"1992","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ophtha.2012.02.018_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1076\/0927-3948(200006)821-0FT093","article-title":"The role of T cells in autoimmune uveitis","volume":"8","author":"Becker","year":"2000","journal-title":"Ocul Immunol Inflamm"},{"issue":"Suppl","key":"10.1016\/j.ophtha.2012.02.018_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000318021","article-title":"New developments in corticosteroid therapy for uveitis","volume":"224","author":"Taylor","year":"2010","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ophtha.2012.02.018_bib9","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/sj.eye.6701792","article-title":"Anti-TNF-alpha therapy for uveitis: Beh\u00e7et and beyond","volume":"19","author":"Murray","year":"2005","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2012.02.018_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000055677","article-title":"Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis","volume":"33","author":"Santos Lacomba","year":"2001","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.ophtha.2012.02.018_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1185\/030079903125002847","article-title":"Tumour necrosis factor-alpha levels in aqueous humour and serum from patients with uveitis: the involvement of HLA-B27","volume":"20","author":"P\u00e9rez-Guijo","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ophtha.2012.02.018_bib12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/BOR.0b013e32825f5481","article-title":"Use of tumor necrosis factor inhibitors in uveitis","volume":"19","author":"Rabinovich","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ophtha.2012.02.018_bib13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/ICU.0b013e3282f03d42","article-title":"Biologics in the treatment of uveitis","volume":"18","author":"Imrie","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.02.018_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10792-011-9430-3","article-title":"Adalimumab (Humira): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmology","volume":"31","author":"Neri","year":"2011","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.02.018_bib15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.2008.092585","article-title":"Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2012.02.018_bib16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/bjo.2006.108050","article-title":"Adalimumab in the therapy of uveitis in childhood","volume":"91","author":"Mansour","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.02.018_bib17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/bjo.2006.103721","article-title":"Adalimumab in the therapy of uveitis in childhood","volume":"91","author":"Biester","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.02.018_bib18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/acr.20404","article-title":"Prevention of flare recurrences in childhood refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab","volume":"63","author":"Simonini","year":"2011","journal-title":"Arthitis Care Res (Hoboken)"},{"key":"10.1016\/j.ophtha.2012.02.018_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00296-009-1178-y","article-title":"Successful switching to adalimumab in an infliximab-allergic patient with severe Beh\u00e7et disease-related uveitis","volume":"31","author":"Takase","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ophtha.2012.02.018_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/jop.2007.0104","article-title":"Adalimumab therapy for refractory uveitis: a pilot study","volume":"24","author":"D\u00edaz-Llopis","year":"2008","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2012.02.018_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data","volume":"140","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2012.02.018_bib22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","article-title":"Standardization of vitreal inflammatory activity in intermediate and posterior uveitis","volume":"92","author":"Nussenblatt","year":"1985","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.02.018_bib23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0197-2456(99)00031-8","article-title":"The Age-Related Eye Disease Study (AREDS): design, implications","volume":"20","year":"1999","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ophtha.2012.02.018_bib24","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ophtha.2006.02.021","article-title":"Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study","volume":"113","author":"Jaffe","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.02.018_bib25","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ophtha.2004.12.034","article-title":"Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series","volume":"112","author":"Nussenblatt","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2012.02.018_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09273940801899822","article-title":"International Uveitis Study Group (IUSG) clinical classification of uveitis","volume":"16","author":"Deschenes","year":"2008","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2012.02.018_bib27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/jop.2008.0073","article-title":"Adalimumab therapy for refractory uveitis: a pilot study [letter]","volume":"24","author":"Callejas-Rubio","year":"2008","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2012.02.018_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1055\/s-2008-1027361","article-title":"Anti-TNF-alpha therapy in patients with chronic non-infectious uveitis: the experience of the Jules Gonin Eye Hospital","volume":"225","author":"Petropoulos","year":"2008","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.ophtha.2012.02.018_bib29","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jpeds.2006.04.058","article-title":"Adalimumab therapy for childhood uveitis","volume":"149","author":"Vazquez-Cobian","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.ophtha.2012.02.018_bib30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/rheumatology\/kem356","article-title":"Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis","volume":"47","author":"Tynj\u00e4l\u00e4","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ophtha.2012.02.018_bib31","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/sj.eye.6702352","article-title":"Adalimumab for sight-threatening uveitis in Beh\u00e7et's disease","volume":"21","author":"Mushtaq","year":"2007","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2012.02.018_bib32","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/ard.2006.052092","article-title":"Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondyloarthropathy: a retrospective study","volume":"65","author":"Guignard","year":"2006","journal-title":"Ann Rheum Dis"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642012001625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642012001625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:02:29Z","timestamp":1758981749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642012001625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0161642012001625"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2012.02.018","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.714947805.790402815","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.714947805.793467431","asserted-by":"object"}]},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2012.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}